1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN

Repligen Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...

Read More
124.97 -3.76 (-2.92%)
28.90% Fall from 52W High
861.0K
XNAS Volume

XNAS 02 Mar, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Repligen Corp is on 13 Mar 2026 for the purpose of Repligen Corp Annual Report for 2025 See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
12.8 / 100
Momentum Score
Technically Neutral
42.3 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
186
1Yr Price target upside is 49%
18 analysts

3

S

15

W

6

O

1

T

SWOT Analysis

Repligen Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..